Physician profile

Justin Hutcheson

Interventional Pain Medicine · Greenville, SC

NPI 1154421915

$22,992.65

in general payments reported to CMS, 2019-2025

49 companies · $4,565 in 2025

The $4,565 reported for 2025 was more than what 90% of Interventional Pain Medicine providers received nationally (typical 2025 total: $676).

See the full distribution for Interventional Pain Medicine

Payments by year

General and research payments by program year, as reported to CMS.

What the payments were for

Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.

View as a table
Payment typeAmount (2023-2025)
Food and Beverage$6,453.43
Travel and Lodging$2,534.76
Education$39.48

Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.

Who reported paying

General payments only, as reported to CMS. Research payments are listed separately below. Product names cover 2023-2025.

CompanyGeneral paymentsYearsTop products
Abbott Laboratories $10,476.41 2019-2025 Proclaim, Eterna, Octrode
Curonix LLC $2,180.22 2024-2025 Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A
Saluda Medical Americas, INC. $1,932.30 2020-2025 Evoke, Evoke Scs
Salix Pharmaceuticals, A Division of Bausch Health US, LLC $1,309.39 2019-2025 Relistor
Boston Scientific Corporation $1,139.62 2019-2025 Intracept, General - Pain Management
Electronic Waveform Lab, INC. $772.38 2019-2023
Scilex Pharmaceuticals INC. $545.07 2019-2024 Ztlido
Nevro Corp. $534.11 2019-2024 Senza
Medtronic, INC. $440.31 2022-2025 Inceptiv, Intellis Adaptivestim
Forte Bio-Pharma LLC $392.96 2019-2025 Prolate, Nalocet, Tanlor
Medtronic USA, INC. $385.43 2019
Spr Therapeutics, INC $246.35 2019-2021
Mml US, INC. $235.23 2021-2023 Reactiv8
Spinal Simplicity, LLC $188.50 2022-2025 Ha Minuteman G3-R
Zynex Medical, INC. $156.06 2025 Nexwave
Show all 49 companies
CompanyGeneral paymentsYearsTop products
Biotronik Nro, INC. $144.52 2025 Prospera
Si-Bone, INC. $139.20 2020-2025
Vertos Medical, INC. $137.67 2020-2024 Mild Device Kit
Novartis Pharmaceuticals Corporation $127.98 2019-2021
Bioventus LLC $115.90 2025 Stimrouter Implantable Kit
Surgalign Spine Technologies, INC. $114.74 2019
Takeda Pharmaceuticals U.S.A., INC. $108.42 2019-2020
Globus Medical, INC. $107.61 2025 Senza
Nalu Medical, INC. $80.32 2021-2023 Nalu Neurostimulation System
Grt US Holding, INC. $75.32 2022
Fidia Pharma USA INC. $71.11 2019
Collegium Pharmaceutical, INC. $67.65 2020-2025 Belbuca
Avanos Medical $56.50 2020-2021
Tonix Medicines, INC. $55.30 2025 Tonmya
Daiichi Sankyo INC. $51.11 2019
Stimwave Technologies Incorporated $50.88 2019
Amgen INC. $49.90 2021-2022
Vertex Pharmaceuticals Incorporated $49.74 2024-2025
Protega Pharmaceutials INC $48.90 2022-2023 Roxybond
Arbor Pharmaceuticals, INC. $48.59 2019-2021
Atland Pharmaceuticals, LLC $45.23 2025 Orphenadrine Citrate, Aspirin and Caffeine, Tolmetin Sodium
Stryker Corporation $42.44 2025
Hikma Pharmaceuticals USA $40.28 2021-2022
Virtus Pharmaceuticals LLC $35.05 2020-2021
Astrazeneca Pharmaceuticals LP $28.39 2019
Pfizer INC. $28.02 2021
Redhill Biopharma INC. $27.76 2020-2022
Alnylam Pharmaceuticals INC. $22.36 2023 Onpattro
Averitas Pharma INC. $20.74 2025 Qutenza
Masimo Corporation $19.17 2023 Set and Rainbow Set
Biodelivery Sciences International, INC. $14.94 2019
Orthogenrx INC. $12.71 2021
Horizon Therapeutics Plc $11.39 2020
Advanced Oxygen Therapy INC. $8.47 2024 Topical Oxygen Chamber For Extremities

Drugs and devices associated with these payments

CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.

Research and ownership

$2,250.00 in research payments reported 2019-2025. Research payments are often institution-directed and tied to clinical trials: they are reported under a clinician's name but frequently go to a hospital or research organization, and usually reflect participation in medical research.

If you want to bring it up

Most clinicians are glad to talk about this. A respectful way in:

These are normal questions. A good clinician will welcome them.

Share this page

Payment summary

Justin Hutcheson

$22,992.65

in general payments reported 2019-2025

Years
2019-2025
Top company
Abbott Laboratories
Context
The $4,565 reported for 2025 was more than what 90% of Interventional Pain Medicine providers received nationally (typical 2025 total: $676).

https://glasscript.com/doctor/143649/justin-hutcheson

Source: CMS Open Payments, program years 2019-2025. Payments are legal and often routine.

Keep an eye on this page

Get an email when the next June refresh changes this page. No account needed.

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.